Quantitation of the antineoplastic agent indicine-N-oxide in human plasma by differential pulse polarography
- PMID: 7205594
- DOI: 10.1002/jps.2600690632
Quantitation of the antineoplastic agent indicine-N-oxide in human plasma by differential pulse polarography
Abstract
A sensitive and reproducible differential pulse polarographic method of analysis was developed for indicine-N-oxide (NSC 132319) in human plasma. Lyophilized plasma is extracted with methanol, and the extract is chromatographed over partially deactivated aluminum oxide and reversed-phase silica gel columns. Indicine-N-oxide is eluted from the silica gel column with 25% aqueous methanol and quantitated by differential pulse polarography by measurement of the peak current at -0.72 +/- 0.03 v (versus the saturated calomel electrode). Recovery of indicine-N-oxide from plasma was 88 +/- 7% (SD) in the 1-20-microgram/ml range. The method was linear over the range of 0.5-10 microgram/ml of pH 4.6 buffer.
Similar articles
-
N-Oxide reduction by hemoglobin, cytochrome C and ferrous ions.Res Commun Chem Pathol Pharmacol. 1980 Oct;30(1):143-50. Res Commun Chem Pathol Pharmacol. 1980. PMID: 6254119
-
Metabolic conversion of indicine N-oxide to indicine in rabbits and humans.Cancer Res. 1979 Sep;39(9):3564-70. Cancer Res. 1979. PMID: 476682
-
Determination of indicine N-oxide and indicine in plasma and urine by electron-capture gas-liquid chromatography.J Chromatogr. 1978 Dec 11;166(2):519-26. doi: 10.1016/s0021-9673(00)95636-x. J Chromatogr. 1978. PMID: 748361
-
Pharmacokinetic study of indicine N-oxide in pediatric cancer patients.Cancer Chemother Pharmacol. 1982 Dec;10(1):43-6. doi: 10.1007/BF00257237. Cancer Chemother Pharmacol. 1982. PMID: 7160044
-
Indicine N-oxide: clinical use of a pyrrolizidine alkaloid.Cancer Treat Rep. 1987 May;71(5):517-23. Cancer Treat Rep. 1987. PMID: 3552221 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources